Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
United Health ProductsUEEC +2.61% EBIT per Share is $-0.01 as of Mar. 2026. The stock has 3 warning signs investors should review. Among 685 Medical Devices & Instruments companies, United Health Products ranks worse than 50.51% on this metric.
United Health Products's EBIT per Share for the
three
months ended in Mar. 2026 was $-0.00.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.01.
During the past 3 years, the average EBIT per Share Growth Rate was 9.10% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 42.80% per year.
During the past 10 years, the average EBIT per Share Growth Rate was -3.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for United Health Products's EBIT per Share or its related term are showing as below:
UEEC'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -138.1 Med: 9.1 Max: 60.7
Current: 9.1
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of United Health Products was 60.70% per year. The lowest was -138.10% per year. And the median was 9.10% per year.
UEEC's 3-Year EBIT Growth Rate is ranked worse than 50.51% of 685
companies
in the Medical Devices & Instruments industry
Industry Median: 9.6
vs UEEC: 9.10
United Health Products (OTCPK:UEEC) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
United Health Products EBIT per Share Related Terms
United Health Products EBIT per Share Historical Data
* Premium members only.
The historical data trend for United Health Products's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
United Health Products (UEEC) has a EBIT per Share of $-0.01 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on United Health Products and its competitors. According to the industry distribution chart, United Health Products ranks #346 out of 685 companies in the Medical Devices & Instruments industry, placing it in the top 50.5%.
Is United Health Products' EBIT per Share too high?
United Health Products' current EBIT per Share is $-0.01. Based on the distribution chart, United Health Products ranks #346 out of 685 companies in the Medical Devices & Instruments industry, which is below the industry midpoint.
How does United Health Products' EBIT per Share compare to FEMY and BNGO?
According to the Medical Devices & Instruments industry distribution chart, United Health Products ranks #346 out of 685 companies for EBIT per Share. This places United Health Products in the lower half of its industry. The industry median EBIT per Share is 9.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.60, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on United Health Products and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. United Health Products's current EBIT per Share is $-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is United Health Products stock overvalued right now?
United Health Products (UEEC) has a current EBIT per Share of $-0.01. The current EBIT per Share is $-0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For United Health Products (UEEC), the current EBIT per Share is $-0.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
United Health Products Inc develops, manufactures, and markets a patented hemostatic gauze for the healthcare and wound care sectors. Its gauze product, CelluSTAT, is derived from cotton and designed to absorb exudate/drainage from superficial wounds and help control bleeding. The company are in the process of seeking regulatory approval to sells hemostatic gauze product line into the U.S. Class III and European CE Mark human surgical markets. The company operates as a single operating segment, focusing on the development and commercialization of medical devices, particularly its patented hemostatic gauze, CelluSTAT.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
UEEC has been successfully added to your 
